hotspot -WSS

hotspot

author：knowledge 2025-10-01 11:00:12 - browse：85

Adam's take main illustration — Molly Ferguson/STAT

MoonLake Immunotherapeutics, a Swiss biotech, was buried Monday under an avalanche of its own data spin.

It’s been awhile since I encountered a management team that speaks so arrogantly about the supposed supremacy of its own drug, but then fails to back up the talk with real data. MoonLake claimed its experimental antibody called sonelokimab delivered “landmark” results in a mid-stage study of psoriatic arthritis.

Landmark? That’s a strange way of describing the results of a clinical trial that showed sonelokimab topping a placebo — an easy hurdle — but failing to separate from an active treatment comparator, the generic drug adalimumab (known better as Humira).

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Paying for Covid pills will soon shift to insurers

leisure time

WSS

Hospitals warn Medicare's drug payment fix is ‘unlawful’

White House announces new plan to address the growing threat of xylazine in overdose crisis

The U.S. needs a new definition of substance use “recovery”

Wisconsin governor employs partial veto to fund schools for 4 centuries

Physician subsidies by hospitals soar in wake of No Surprises Act

Swim instructor mom warns parents not to buy blue swimsuits for kids

knowledge

hotspot

hotspot

Medicare proposal to cover medical devices draws a mixed reaction

Biden targets hefty hospital 'facility fees' that often surprise patients

How one medical school became remarkably diverse

First Opinion Podcast: How to protect health care in times of war

Medical records are filled with copy

White House announces new plan to address the growing threat of xylazine in overdose crisis

Anesthesiologist group: stop taking Ozempic before surgery

Telehealth options flood the market as retailers push virtual care

Drug repurposing or repositioning? The language matters

WHO may add ‘noma' to its list of neglected tropical diseases

focus

Judge agrees to delay next hearing in Trump classified documents case

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

ACA's risk program benefits Blue Cross Blue Shield insurers

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

hotspot

knowledge

leisure time

leisure time